Sector: Health Care
Director information for STRYKER CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Andrew K. Silvernail | Director; Chairman, Chief Executive Officer | 55 | ["Chairman, Chief Executive Officer, International Paper (2024-present)", "Chairman, President and Chief Executive Officer, Madison Industries (2021)", "Chairman, President and Chief Executive Officer, IDEX Corporation (2011-2020)", "Vice President, Group Executive (2009-2011)", "Director, Boys & Girls Club of Lake County"] | ["Audit (Chair)", "Audit"] | 2026 |
| Emmanuel P. Maceda | Director; Chair, Bain & Company | 63 | ["Worldwide Managing Partner and CEO, Bain & Company (2018-2024)", "Various leadership roles with Bain & Company (1989-2018)", "Board of Trustees, The Bridgespan Group", "Director, Ayala Corporation"] | ["Comp&HC", "G&N", "Compensation and Human Capital", "Governance and Nominating"] | 2026 |
| Giovanni Caforio, M.D. | Director; Chief Executive Officer | 61 | ["Chief Executive Officer, Bristol-Myers Squibb (2015-2023)", "Chairman of the Board (2017-2024)", "Various leadership roles with Bristol-Myers Squibb (2000-2015)", "Chair of the Board, Novartis AG", "Director, Pharmaceutical Research and Manufacturers of America"] | ["Comp&HC (Chair)", "G&N", "Compensation and Human Capital", "Governance and Nominating"] | 2026 |
| Kevin A. Lobo | Director; Chair, Chief Executive Officer and President | 60 | ["Chair and Chief Executive Officer, Stryker (2018-2021, January 2026-present)", "Chair, Chief Executive Officer and President (2014-2018, 2021-2025)", "Chief Executive Officer and President (2012-2014)", "Group President, Stryker Orthopaedics (2011-2012)", "Various leadership roles with Johnson & Johnson (2003-2011)", "Director, The Advanced Medical Technology Association (AdvaMed)", "Director, Parker-Hannifin Corporation", "Chair, Valley Health System Board of Trustees"] | [] | 2026 |
| Lisa M. Skeete Tatum | Director; Founder and Chief Executive Officer | 58 | ["Founder and Chief Executive Officer, Landit, Inc.", "Angel and Fund Investor", "General Partner, Cardinal Partners", "Founder, STI, Inc.", "Various global and functional roles with Procter and Gamble", "Board Member, Union Square Hospitality Group", "Director, USHG Acquisition Corporation", "Trustee Emeritus, Cornell University"] | ["Audit"] | 2026 |
| Mary K. Brainerd | Director; President and Chief Executive Officer | 72 | ["President and Chief Executive Officer of HealthPartners (2002-2017)", "Various leadership roles with HealthPartners (1992-2002)", "Various leadership roles with Blue Cross and Blue Shield of Minnesota (1984-1992)", "Director, Bremer Financial Corporation", "Director, Securian Financial", "Vice Chair, The Nature Conservancy, Minnesota-North Dakota-South Dakota", "Director, The Opus Group"] | ["Comp&HC", "G&N (Chair)", "Compensation and Human Capital", "Governance and Nominating"] | 2026 |
| Rachel M. Ruggeri | Director; Executive Vice President and Chief Financial Officer | 56 | ["Executive Vice President and Chief Financial Officer, Starbucks Corporation (2021-2025)", "Senior Vice President, Americas, Starbucks (2020-2021)", "Chief Financial Officer and Corporate Secretary, Continental Mills, Inc. (2018-2020)", "Various leadership roles with Starbucks Finance (2001-2018)"] | ["Audit"] | 2026 |
| Rajeev Suri | Chief Executive Officer and Director | 58 | ["Chief Executive Officer and Director, Inmarsat (2021-2023)", "President and Chief Executive Officer, Nokia (2014-2020)", "Chief Executive Officer, Nokia Solutions and Networks (2009-2014)", "Various leadership roles with Nokia (1995-2009)", "Chairman of the Board, Digicel Group", "Chairman of the Board, M-KOPA", "Director, Singtel", "Chairman of the Advisory Board, Netceed", "Director, Viasat (2023-2025)"] | ["Audit"] | 2026 |
| Ronda E. Stryker | Director | 71 | ["Director of Stryker Corporation for over 40 years", "Vice Chair and Director, Greenleaf Trust (1988-present)", "Vice Chair, Spelman College Board of Trustees", "Member, Harvard Medical School Board of Fellows"] | ["G&N", "Governance and Nominating"] | 2026 |
| Sherilyn S. McCoy | Lead Independent Director | 67 | ["Chief Executive Officer and Director, Avon Products, Inc. (2012-2018)", "Various leadership roles with Johnson & Johnson (1982-2012)", "Director, AstraZeneca PLC", "Lead Director, Kimberly-Clark", "Vice-Chair of the Board, Galderma", "Director, Novocure (2018-2022)", "Chair of the Board, Certara, Inc. (2018-2021)"] | ["Comp&HC", "G&N", "Compensation and Human Capital", "Governance and Nominating"] | 2026 |
